Bioinformatics Videos

1. How Can We Make Drug Discovery Faster And Smarter? 2/3/2026

   DEL technology is evolving from a screening tool into a rich data engine for AI. Learn how expanding datasets and computational methods are reshaping what researchers can uncover.

2. What Are The Benefits Of Combing AI And DELs For Drug Discovery? 1/26/2026

   Discover how AI-powered modeling uncovers hidden patterns in DEL data, broadens chemical diversity, and accelerates decision-making to help teams prioritize compounds and move more efficiently.

3. Will NAMS Replace Animal Testing By 2030? 10/27/2025

   Panelists debate whether NAMS can replace 10% of animal testing for regulatory submissions by 2030. Shashi asserts that big pharma is already reducing animal use, while Samantha cites the EU’s success in cosmetics and FDA’s roadmap for monoclonals. Zaher predicts over 50% replacement by 2030, citing OECD updates and liver injury data.

4. Global Momentum & Data Sharing: The Next Frontier 10/27/2025

   Zaher compares EU and U.S. progress, noting legislative and policy shifts driving NAMS integration. Samantha calls for open data platforms and consortiums to build confidence, while Zaher stresses benchmarking against human clinical data and government-led initiatives akin to the Human Genome Project.

5. The NAMS Revolution: Why Now? 10/27/2025

   Zaher frames the urgency of NAMS adoption by highlighting the staggering 92% drug failure rate in clinical trials despite animal testing. He explains how interdisciplinary convergence and AI are accelerating the shift toward human-relevant models, positioning NAMS as a solution to systemic inefficiencies in drug development.

6. An AI Awakening With Profluent Bio's Hilary Eaton, Ph.D. 9/22/2024

   Hilary Eaton, Ph.D. was a self-described AI skeptic, particularly regarding using the tool in drug discovery. Then, a series of professional and deeply personal life events and medical discoveries put her in a position to confront that skepticism head-on. On Business of Biotech, the Chief Business Officer at ProFluent Bio shares her story and makes a pragmatic case for the transformative value of AI to biotech builders.

7. Predictive Data Modeling Using AI/ML For Early Identification Of High-Producing Clones 8/5/2024

   Watch to learn how an innovative clone-selection technology can improve your cell line development.

8. Innovative AI-Driven Solutions To Address The Growing Complexity Of APIs 7/30/2024

   Computer-aided synthesis planning (CASP) can mitigate the impact of rising complexity. Here, we discuss the award-winning AI and vast data that propel a leading predictive retrosynthesis technology.

9. First AI Antibody In Humans with Aulos' Aron Knickerbocker 7/14/2024

   Data drives decision-making at Aulos Bioscience. It's also driven the career trajectory of its CEO. On this week's episode of the Business of Biotech podcast, we get an introspective walk through Aron Knickerbocker's strategically-orchestrated career path, from his early days in the labs at Bristol-Myers Squibb and Genentech to his leadership of Aulos Bioscience, a company that boasts the first AI-generated antibody in human clinical trials.

10. How Generative AI Enhances Creativity In Biotech 5/29/2024

    AI and ML marry computational science to biology, creating new opportunities for biotech.